SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Auro Laboratories - Quaterly Results

14 Aug 2025 Evaluate
The Sales for the quarter ended June 2025 of Rs. 27.74 million declined by -51.50% from Rs. 57.20 millions.The Net Loss for the quarter ended June 2025 is Rs. -1.05 millions as compared to Net Profit of Rs. 7.53 millions of corresponding quarter ended June 2024Operating Profit reported a sharp decline to 4.50 millions from 15.26 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 27.74 57.20 -51.50 27.74 57.20 -51.50 193.98 536.35 -63.83
Other Income 4.16 2.03 104.93 4.16 2.03 104.93 6.56 15.04 -56.38
PBIDT 4.50 15.26 -70.51 4.50 15.26 -70.51 40.59 121.74 -66.66
Interest 2.81 2.50 12.40 2.81 2.50 12.40 10.82 7.36 47.01
PBDT 1.69 12.76 -86.76 1.69 12.76 -86.76 29.77 114.38 -73.97
Depreciation 2.74 2.70 1.48 2.74 2.70 1.48 10.96 10.92 0.37
PBT -1.05 10.06 -110.44 -1.05 10.06 -110.44 18.81 103.46 -81.82
TAX 0.00 2.53 0.00 0.00 2.53 0.00 0.42 25.54 -98.36
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.61 -1.87 -67.38
PAT -1.05 7.53 -113.94 -1.05 7.53 -113.94 18.39 77.92 -76.40
Equity 62.32 62.32 0.00 62.32 62.32 0.00 62.32 62.32 0.00
PBIDTM(%) 16.22 26.68 -39.19 16.22 26.68 -39.19 20.92 22.70 -7.81

Auro Laboratories Share Price

261.00 -7.65 (-2.85%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×